(Q39748724)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

14 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer (English)

1 reference

14 September 2017

María E Fermento

1

1 reference

14 September 2017

Norberto A Gandini

2

1 reference

14 September 2017

Cecilia A Lang

3

1 reference

14 September 2017

Juan E Perez

4

1 reference

14 September 2017

Horacio V Maturi

5

1 reference

14 September 2017

Alejandro C Curino

6

1 reference

14 September 2017

María M Facchinetti

7

1 reference

14 September 2017

25 January 2010

1 reference

Experimental and Molecular Pathology

14 September 2017

1 reference

14 September 2017

88

1 reference

14 September 2017

2

1 reference

14 September 2017

256-264

1 reference

The proteasome: a macromolecular assembly designed for controlled proteolysis

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

The proteasome: a suitable antineoplastic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Recruitment of p300/CBP in p53-dependent signal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Role of Akt/protein kinase B in the activity of transcriptional coactivator p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Ubiquitin-dependent distribution of the transcriptional coactivator p300 in cytoplasmic inclusion bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Association of p300 and CBP with simian virus 40 large T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Hassles with taking out the garbage: aggravating aggresomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Mutations truncating the EP300 acetylase in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Expression of HDAC1 and CBP/p300 in human colorectal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Aggresomes: a cellular response to misfolded proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Aggresomes, inclusion bodies and protein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

ER quality control: the cytoplasmic connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Regulation of autophagy by the p300 acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

The ubiquitin-proteasome pathway and its role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Proteasome inhibitors: antitumor effects and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse alphaA-crystallin locus in lens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.01.007

https://opencitations.net/index/api/v1/references/10.1016/J.YEXMP.2010.01.007

7 January 2021

1 reference

30 December 2023

Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.YEXMP.2010.01.007

Identifiers

DOI

10.1016/J.YEXMP.2010.01.007

1 reference

14 September 2017

1 reference